Mentor’s Stock Jumps In Q3 On Silicone Implant “Approvable” Letter
This article was originally published in The Gray Sheet
Executive Summary
FDA's "approvable" letter to Mentor for the Memory Gel silicone breast implants drove the firm's stock up 32.6% to $55.01 for the quarter, but investor tunnel-vision could keep future stock movement tied to FDA's final decision